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Abbreviations: UB, ureteric bud; MM, metanephric mesenchyme; UM, ureteric mesenchyme; UPJ, ureteropelvic junction; UVJ, ureterovesical junction; CAKUT, congenital anomalies of the kidney and urinary tract; RAS, renin-angiotensin system
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pediatric population.2 There are different types of obstructive nephropathy based on the location of the obstruction and/or the cause of
the obstruction. Obstruction at the junction between the ureter and
the renal pelvis is called Ureteropelvic Junction (UPJ) obstruction,
which usually presents as hydronephrosis without obvious dilatation
of the ureter (hydroureter). UPJ obstruction is estimated to occur
in one out of 1,000–1,500 new births. Obstruction at other levels,
such as ureterovesical junction (UVJ) and bladder outlet are also
common. Obstruction in the urinary tract, in a strict sense, describes
the presence of a physical blockage to the urine flow. However,
the word “obstruction” is also used to describe the failure of urine
transport from the kidney to the external environment regardless of
the causes. The word “obstruction” is used in this manuscript in its
broader sense to describe the physical blockage (physical obstruction) of the urinary tract and functional failure in urine transport
(functional obstruction).
Experimental surgical animal models for obstructive nephropathy
have been very useful in determining the pathologic impacts of the
obstruction but less informative about the molecular and cellular
lesions causing the disease.3-12 Despite this progress, the genetic or
environmental determinants in most human patients with congenital
defects in the kidney and the urinary tract are not known. In addition
to familial cases, strong genetic determinants in congenital kidney
and urinary tract defects were reported by a number of studies in
seemingly sporadic cases.13-15 For example, Feather et al. found that
there is a 30–50 fold increased incidence of vesicoureteral reflux in
first-degree relatives of probands, compared with the general population.14 The strong genetic component in congenital kidney and
urinary tract defects demands more studies in the genetic factors and
pathways involved in the pathogenesis of these devastating diseases.
Mouse models, both genetically engineered and naturally occurring,
have been making and will continue to make major contributions
to these studies. Pathological consequences of congenital obstructive
nephropathy have been described in detail from both human and
animal studies for decades.16-21 The molecular and cellular lesions
causing congenital urinary tract obstruction only started to come
to light in recent years. Results from both genetically engineered
and spontaneously occurring mouse models have revealed a high
degree of heterogeneity in the origins of obstructive nephropathy
and the developmental processes where most of the disease-causing
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Urinary tract obstruction leads to obstructive nephropathy,
which in turn, frequently results in renal failure. Congenital
urinary tract obstruction can be traced back to errors during the
organogenesis of the urinary system. A fundamental understanding
of the causes of urinary tract obstruction and the developmental
processes involved are critical for improving the diagnostic and
therapeutic strategies for this disease. A number of laboratories,
including ours, have been using genetically engineered and spontaneously occurring mouse models to study the primary causes and
the pathogenesis of urinary tract obstruction. These studies have
shown that urinary tract obstruction is a very heterogeneous disease
that can be caused by a diverse set of factors targeting multiple
levels of the urinary system. Accumulating evidence also indicates
that the development of the urinary tract requires the integration
of progenitor cells of diverse embryonic origins, leading to the
formation of multiple junctions prone to developmental errors.
In addition, the high sensitivity of the pyeloureteral peristaltic
machinery to disturbance affecting the structural or functional
integrity of its components also contributes to the high incidence
rate of urinary tract obstruction.
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Congenital obstructive nephropathy is the principal cause of renal
failure in the pediatric population. Compared to adults, urinary tract
obstruction in children is particularly damaging due to the permanent impairment inflicted on the maturing kidneys. If left untreated,
congenital obstructive nephropathy can lead to renal failure and even
death.1 Congenital obstructive nephropathy is not only a devastating
disease, but also a very common one. Hydronephrosis is found in
antenatal screening at 1:100 with about 1 in 500 being clinically
significant, making it the leading cause for renal failure in the
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anomalies occur.22 Continuing
advances in mouse genetics and
genomics will no doubt speed up
the identification of the genetic
factors and pathways involved in
the pathogenesis of obstructive
nephropathy.
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Loss of Calcineurin in the
Metanephric and Ureteric
Mesenchyme causes Congenital
Obstructive Nephropathy
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Our interest in congenital
obstructive nephropathy originated
from the study of the calcineurin
mutant mice. Calcineurin is a
Ca2+-dependent serine/threonine
phosphatase composed of a catalytic subunit, CnA and a regulatory
subunit, CnB (Fig. 1). CnB has
a ubiquitously expressed isoform
(Cnb1) and a testis-specific isoform
(Cnb2). The regulatory subunit
of calcineurin is indispensible for
calcineurin activity.23,24 Thus inactivation of Cnb1 in non-testis cells
will render those cells deficient for
Figure 1. The Calcineurin-NFAT signaling pathway. Calcineurin is a calcium-dependent serine-threonine phoscalcineurin function.25 The NFATc phatase. Calcineurin has a catalytic subunit “A” and a regulatory subunit “B”. Both of these subunits are
(Nuclear Factor of Activated T indispensible for calcineurin activity. The activity of calcineurin can be inhibited by a number of intrinsic and
Cells) transcription factors are the pharmacological inhibitors, such as Cyclosporin A (CsA) and FK506. The increase in cytoplasmic calcium level
most extensively studied calcineurin can be triggered by many factors, including the activation of a diverse set of cell surface receptors, ion channels
substrates. They appear to be the and even gap junctions. Intracellular calcium increase leads to the activation of calcineurin. Activated calcineurin
dephosphorylates its substrates, including the NFATc transcription factors. The dephosphorylated NFATc proteins
major regulator of transcription translocate from the cytoplasm to the nucleus to regulate the transcription of their target genes. The regulation
downstream of Ca2+/Calcineurin of transcription by NFATc proteins requires nuclear partners (NFATn). These nuclear partners can be different
signals.24 NFATc proteins reside in for different target genes and in different cells. These nuclear partners are usually activated by a different set of
the cytoplasm in resting cells. Upon receptors on the cell surface.
activation by an increase in intracellular Ca2+, calcineurin dephosphorylates the NFATc proteins. This deleted in the MM and UM (Fig. 2F–I). The blood urea nitrogen
dephosphorylation exposes the concealed nuclear localization signals (BUN) level in the mutants is on average more than 10 times higher
of the NFATc proteins, leading to translocation from the cytoplasm than that of the controls. All mutants died of renal failure within 3
to the nucleus. Once in the nucleus, the NFATc proteins form NFAT weeks after birth.
transcription complexes with their nuclear partners to control the
Calcineurin is Required for the Development of the
transcription of target genes.
In an earlier study, we used a Pax3-Cre transgene to direct the Pyeloureteral Peristaltic Machinery
deletion of a loxP-flanked Cnb1 allele and serendipitously created a
We further showed by polymer molding that the mutant urinary
model for congenital obstructive nephropathy.26 The Pax3-Cre trans- tract is not physically obstructed. Instead, the pyeloureteral peristalsis
gene (Pax3-Cre) was originally generated to direct the recombination is defective in the Pax3-CreT/+; Cnb1lox/lox mutants, leading to failure
of loxP sites in neural crest cells and other tissues.27 Our analyses of urine transfer and functional obstruction.26,29 A key reason for
of mice carrying the Pax3-Cre transgene and the ROSA26RLacZ the functional obstruction is the defective development of the renal
(ROSA) allele28 revealed that, within the urinary system, this trans- pelvis and smooth muscle along the urinary tract. The mutants fail
gene is expressed specifically in the metanephric mesenchyme (MM) to form the funnel-shaped muscular structure of the renal pelvis that
and ureteric mesenchyme (UM) derived tissues (Fig. 2A–E), but not is important for normal peristalsis (Fig. 3A and B). The defective
in ureteric bud (UB) derived tissues. Especially, the smooth muscle development of the renal pelvis is, in turn, caused by reduced prolifcells of the renal pelvis and ureter (mesenchymal derivatives) have eration of the smooth muscle cells and their progenitors lining the
strong Cre expression as evidenced by the strong β-galactosidase developing renal pelvis. Ki67 staining revealed a reduction of prolifactivity in these cells (Fig. 2B–E). We unexpectedly discovered severe eration in the mesenchymal cells with calcineurin deficiency but not
hydronephrosis in mutant mice (Pax3-CreT/+; Cnb1lox/lox) with Cnb1 in the epithelium that retains calcineurin activity (Fig. 3C and D).
298

Organogenesis

2008; Vol. 5 Issue 1

Urinary tract development and diseases

DI
ST

RI

BU
T

E.

Figure 2. Inactivation of Cnb1 in the metanephric and ureteric mesenchyme
causes congenital obstructive nephropathy. (A–E) are samples from P1
Pax3-CreT/+, ROSAT/+ mice. In the kidney proper, LacZ expression (blue,
reflecting the Cre expression) is evident in the glomeruli and tubules that are
MM-derived but not in the collecting duct system originated from the UB (A).
The black arrow in (B) points to the developing glomeruli. The open arrow
points to one of the UB branches. In the developing renal pelvic region, the
connective tissues, the smooth muscle layers (SM) and the adventitia (AD) of
the urinary tract express LacZ while the UB-derived urothelium (UT) remains
LacZ-negative (C–E). U: ureter; PP: Papilla. The SM layers in the developing
renal pelvic wall are illustrated by αSMA staining on a wild-type newborn
sample of the same area (D). LacZ is also selectively expressed in the SM
layers in the ureter but not in the stratified transitional epithelium (E). Mutants
(Pax3-CreT/+, Cnb1lox/lox) have severe hydronephrosis and erosion of the
kidney parenchyma (G and I compared with F and H. Samples G and H
were collected at P12). Modified from Figures 2 and 3 from ref. 26 with
permission.

Interaction of Signaling Pathways in Urinary Tract
Development
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The renal pelvis is critical for normal urine transfer in at least three
ways. First, constriction of the junction between the renal pelvis and
the ureter (ureteropelvic junction, UPJ) can lead to obstruction to
the urine flow. Second, it has been proposed that the pacemakers for
pyeloureteral peristalsis reside in the renal pelvis.30 These pacemaker
cells are thought to be specialized smooth muscle cells that control
the initial contraction of the smooth muscles lining the urinary
tract. Third, the contraction of the funnel-shaped muscular structure
of the renal pelvis provides the strong initial thrust that effectively
propels urine down the ureter from the pelvicocaliceal space inside
the kidney. Spontaneous peristalsis was observed in pyeloureteral
complexes removed from the Pax3-CreT/+; Cnb1lox/lox mutants,
suggesting that the pacemaker cells were still present in the mutants
for the initiation of peristalsis. As revealed by polymer molding of
the urinary tract in the mutants, physical constriction of the UPJ
was not observed. Thus defective development of the “powertrain”
for peristalsis (the renal pelvis and smooth muscle along the
urinary tract) in the Pax3-CreT/+; Cnb1lox/lox is the major cause
for the ineffective urine transfer and functional obstruction of
the urinary tract.26

©

Figure 3. Inactivation of Cnb1 in the metanephric and ureteric mesenchyme
disrupts the development of the pyeloureteral peristaltic machinery. (A and B)
are hemi-sected control (A) and mutant (B) kidneys. The white arrows point to the
UPJ. (C and D) are sections of the developing renal pelvic wall of control (C) and
mutant (D) immunostained with a Ki67 antibody. The controls have significantly
more proliferating mesenchymal cells along the developing renal pelvic wall. PP:
papilla. M: mesenchymal derivatives. UT: urothelium. Modified from Figures 5
and 7 from ref. 26 with permission.
www.landesbioscience.com

Since not all tissues and cells with Cnb1 deletion have reduced
proliferation, we believe that calcineurin is not simply serving as
a generic proliferation regulator in the MM and UM. Instead, it
functions as a key factor in the mesenchyme for the interpretation
of signals that originate in the UB-derived epithelium. A number
of factors have important functions in the UB derivatives for
urinary tract development.22 Among these factors, Shh communicates with its receptor Ptch in the mesenchyme to regulate
smooth muscle differentiation.31 The deletion of Shh in the UB
derivatives leads to defective smooth muscle development and
obstructive nephropathy. In addition, Dlgh1 is expressed strongly
in the epithelium, though it also has expression in the mesenchyme. Its inactivation results in a range of urogenital defects,
including urinary tract smooth muscle defects and obstructive
nephropathy.32,33 Since many signaling pathways directly or
indirectly induce calcium increase in the target cells, it will not be
surprising to see that the calcineurin signaling is embedded in a
more complex signaling network and is constantly being modified
by other interacting signals. The Renin-Angiotensin system (RAS)
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Figure 4. Genetic mapping of the cph mutants with congenital obstructive nephropathy. (A–C) The mutants have unilateral or bilateral hydronephrosis and
hydroureter (arrow). (D) The BUN level in the mutants (P5-P16) is dramatically increased. (E and F) Kidney sections from P14 control and mutant littermates
stained with H&E. (G) Physical map of relevant portions of mouse chromosome 15. Our genetic mapping efforts locate the cph locus to the chromosomal
interval of about 0.7 Mbp, defined by the microsatellite markers C15LD6 and C15LD5. The black triangle indicates the chromosomal location of Aqp2.
Modified from Figures 1 and 3 from ref. 43 with permission.
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is known to be involved in renal injury in congenital obstructive
nephropathy. RAS, however, has a constructive role during urinary
tract development.34,35 Mutations in a number of RAS component
genes cause congenital anomalies of the kidney and urinary tract
(CAKUT).36-42 Although the broad effect of RAS in blood pressure control and regulation of the ability to concentrate urine may
contribute to the observed renal pathological changes, evidence
suggests that direct function of RAS in the ureteral SM differentiation plays an important role.38 In fact, a number of studies suggest
that RAS can induce activation of calcineurin. Our recent studies
indicate that transgenic activation of Nfatc1 in the urinary tract also
leads to severe developmental anomalies including hydroureters and
hydronephrosis (Wang and Chen F, unpublished data). It is possible
that within the urinary system, RAS activates calcineurin to regulate
Nfat-mediated transcription for proper urinary tract development
and differentiation.

©

Genetic Mutations causing Congenital Obstructive
Nephropathy
Besides genetically engineered mice, the identification of unknown
causative mutations in mice with congenital obstructive nephropathy
is another way to reveal the genetic determinants in this disease. One
example of such forward genetic studies is the identification of the
300

genetic mutation in the cph (congenital progressive hydronephrosis)
mice.43 cph was first discovered as a spontaneous, autosomal recessive trait in the 1970s.44,45 Since these mutants were thought to
have renal cysts, they were named jpk for Juvenile Polycystic Kidney
until a later study found that the pathologic changes were cystic
renal dysplasia caused by progressive hydronephrosis secondary to
UPJ obstruction.45 We performed a thorough analysis of the urinary
system in the cph mutants and found that besides UPJ obstruction,
some of them also have UVJ obstruction and hydroureter.43 Based
on polymer molding, there is no physical blockage of the urinary
tract, suggesting another example of functional obstruction. Early
postnatal hydronephrosis usually progresses rapidly, leading to loss of
renal function and death (Fig. 4A–F). To identify the causative mutation, we performed genetic mapping that located the cph mutation to
a 0.7 Mb chromosomal region on mouse chromosome 15 (Fig. 4G).
There were still approximately 30 known genes and predicted open
reading frames in this interval.43
After studying the genes within the suspected chromosomal
interval, we discovered that the distribution of the water channel
protein Aqp2 was altered in the mutants. Aqp2 functions as a water
channel to reabsorb water from the collecting duct lumen back to
the interstitium. While Aqp2 was predominantly distributed on
the apical membrane of the principal cells in the collecting ducts
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highly conserved in all vertebrate species. The loss of this
key phosphorylation due to the cph mutation results in the
loss of apical trafficking of the Aqp2 protein. The direct
physiological effect of this trafficking defect is in urine
concentration. As a consequence, the cph mutants produce
a high volume of hypotonic urine and show classic characteristics of Nephrogenic Diabetes Insipidus, including
insensitivity to vasopressin.43 The cph mutants were first
described as having polycystic kidney disease, before it
was later found to have progressive hydronephrosis and
obstructive nephropathy instead. Our study shows that the
underlying cause is in Aqp2 distribution and urine concentration. They actually have Nephrogenic Diabetes Insipidus
and the drastic increase of urine output overwhelms the
urine transfer machinery, secondarily causing hydronephrosis. Many diseases share similar structural anomalies and
present with similar symptoms, but accurate diagnosis can
only be made by revealing the underlying molecular and
cellular lesions.

Diverse causes of Obstructive Nephropathy
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Our ongoing research involves other urinary tract
disease models that are either spontaneously occurring
murine mutants, transgenic mice with alterations in
specific genes, or transgenic mice with specific ablation of
progenitor cells involved in the development of the urinary
system. As we learn from our own studies and studies from
many other laboratories, obstructive nephropathy can be
caused by a diverse set of factors targeting different parts
of the urinary system.22,46 Most of the known causes affect
the development of the lower urinary tract. These include
the underdevelopment of the pelvis and the malformation
Figure 5. A mutation in Aqp2 disrupting its trafficking causes urine concentration defect
of the ureteric smooth muscle as we see in the calcineurin
and obstructive nephropathy. (A and B) Immunostaining of the collecting ducts in the
mutants. Defects in the ureteric epithelium can directly
outer medulla shows apical accumulation of Aqp2 in the controls (A) but a diffuse staining with no apical accumulation in the mutant (B). (C) Sequence of the fourth exon of or indirectly affect the pyeloureteral peristalsis, leading to
Aqp2 reveals the C-T substitution at nucleotide 767 in the homozygous mutants, while obstruction. The joining of the ureter to the bladder is a
the heterozygotes have both C and T represented at position 767. This substitution complex process where errors are prone to occur.47-49 As
results in a Ser to Leu change at amino acid 256 in the cytoplasmic tail of the Aqp2 seen in the cph mutants, in addition to problems in the
protein. +, wild-type allele; c, cph mutant allele. Modified from Figure 3 from ref. 43
lower urinary tract, anomalies in the kidney proper can
with permission.
also lead to physiological changes that eventually break
down the urine transfer machinery, causing obstruction.
in control mice, its apical accumulation was completely lost at all The essential pyeloureteral peristalsis is a process that requires high
levels of the collecting duct in all homozygous mutants (Fig. 5A structural and functional integrity of all of its components, making
and B). At that point, we could not be certain if the observed it sensitive to disturbances caused by genetic and environmental
difference in distribution was merely a pathological change due to factors. Perhaps this sensitivity of pyeloureteral peristalsis to such
obstructive nephropathy or was in fact the cause for the renal defects. disturbances and the complexity in the formation of the junctional
We thus examined the distribution of Aqp2 in the principal cells of complexes along the urinary conduit set the stage for the high incithe Pax3CreT/+; Cnb1lox/lox mutants that also have severe congenital dence of congenital urinary tract obstruction (Fig. 6).
obstructive nephropathy.26 The distribution of Aqp2 was not signifiA Systematic View of the Development of Urinary Tract
cantly changed in the Pax3CreT/+; Cnb1lox/lox mutants despite overt
collecting duct dilatation (data not shown), suggesting that absence Obstruction
of Aqp2 apical accumulation was not simply a secondary effect of the
Development of the urinary tract requires the integration of
congenital obstructive nephropathy.
progenitor populations with diverse embryonic origins (Fig. 6).
By sequencing the Aqp2 gene, we discovered a mutation in The majority of the nephron components are from the MM within
nucleotide 767 in the fourth exon of Aqp2 in the mutants (Fig. the intermediate mesoderm. The UB contributes to the ureteric
5C). The C-T change in codon 256 led to a Ser to Leu substitution epithelium and the collecting duct epithelium.50,51 The tailbudin the protein. This S256 is actually a phosphorylation site and is derived mesenchyme gives rise to the UM which, in turn, produces
www.landesbioscience.com
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Figure 6. Urinary tract development requires the integration of diverse progenitor cell populations and the formation of multiple junctions. Nephron components, excluding the collecting ducts, are derived from the MM within the intermediate mesoderm. The collecting duct and the ureteric epithelium are derived
from the UB. The tailbud-derived mesenchyme gives rise to the UM that in turn produces the smooth muscles and other mesenchymal derivatives along the
ureter and along the ureter. While the vesical (bladder) epithelium is from the hindgut endoderm, the vesical mesenchyme appears to arise from tailbudderived mesenchyme. The lineage origin of the urethral mesenchyme is not entirely clear, but the urethral epithelium is also derived from the same hindgut
endoderm that gives rise to the vesical epithelium. The origin of the renal capsule is less clear but appears to be distinct from the other structures within the
urinary system. The use of different colors is for the distinction of tissues with different embryonic origins. The different colors used for the UM and vesical mesenchyme (both from the tailbud-derived mesenchyme) reflect the fact that they develop as separate structures before being joint together later in development.
The entire urinary tract is also highly innervated. The integration of these diverse progenitor populations also involves the formation of junctional complexes,
especially at the UPJ and UVJ. Any disruption of the regulation of the integration could lead to urinary defects, including urinary tract obstruction.
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to position closer to the middle than normal. This sets up an unstable
state that any slight variation may cause fusion of the MM from
both sides and, subsequently, the formation of horseshoe kidneys.
The ascent of the horseshoe kidneys tends to be impeded by crossing
blood vessels, causing subsequent problems such as hydronephrosis
and hydroureter. However, if no fusion occurs, the left and right
kidneys may develop relatively normally despite their unusually
close proximity to each other. Therefore, very slight and random
variations may separate a rather healthy state and a potentially very
morbid state.

RI

Conclusions

NO

T

DI
ST

Genetically engineered and naturally occurring murine models are
powerful tools in the study of congenital obstructive nephropathy.
With the advance of mouse genetics and genomics, the use of these
tools will certainly expand. While we now have a much better understanding of urinary tract development and the causes of congenital
urinary tract obstruction than a decade ago, identifying the cause
and determining the most suitable treatment for a particular patient
remain a challenge for basic researchers and clinicians to tackle for
years to come.
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Conference Questions and Answers
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Dr. Paul Austin, Associate Professor of Surgery, Washington
University School of Medicine: When do the cph mutants die?
Dr. Chen: Usually they die within the first month.
Dr. Austin: Are they normal at birth?
Dr. Chen: Yes, at birth they look normal. The hydronephrosis
usually becomes obvious within the first week of life.
Dr. Eduardo Slatopolsky, Joseph Friedman Professor of Medicine,
Washington University School of Medicine: You indicate that polyuria
will induce breakdown of the peristaltic machinery and that produces
renal insufficiency. Most patients with diabetes insidious do not have
a decrease in renal function. Why is it different in the mice?
Dr. Chen: Patinents with diabetes insipidus can have hydronephrosis and hydroureter, if they don’t take medication and drink too
much. Mice drink as much as they want and are not medicated. It is
possible that polyuric mice are more prone to hydronephrosis than
polyuric humans. In any case, I think the breakdown of the peristaltic machinery induced by polyuria is the most likely explanation
for the functional obstruction in the cph mice.
Dr: Austin: I would agree with you because we see clinically
that pediatric patients with polyuria can overwhelm their bladder
capacity. This results in a functional obstruction that can cause renal
scarring. In many of those kids, we recommend over night Foley
drainage to decompress the bladder and prevent elevated pressure
from the functional obstruction.
Dr. Chen: Right. Thanks.
Dr. Slatopolsky: You showed that a mutation in Aqp2 disrupting
its trafficking causes urine concentration defect and obstructive nephropathy. Did you have the opportunity to study the osmolality of the
medulla of those animals. If you don’t have a hypertonic medulla,
even if you have a working aquaporin, you cannot concentrate the
urine, and you get polyuria. You need both a functional aquaporin
and you need hypertonic medulla.
Dr. Chen: That is a good point. We did not measure the
osmolality of the mutant medulla. However, one would expect
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the smooth muscle and other mesenchymal derivatives along the
ureter and along the ureter.52 While the vesical (bladder) epithelium
is from the hindgut endoderm, the vesical mesenchyme appears to
arise from tailbud-derived mesenchyme.52 The lineage origin of the
urethral mesenchyme is not entirely clear, but the urethral epithelium
is also derived from the same hindgut endoderm that gives rise to the
vesical epithelium.53 The temporal and spatial integration of these
diverse progenitor populations requires precise control by a number
of signaling pathways. Any disruption of these signaling pathways
could affect the integration, leading to a wide range of renal defects,
including agenesis, hypoplasia, supernumerary ureter, hydroureter,
hydronephrosis and others. Presence of multiple types of defects in
the kidney and the urinary tract is described as CAKUT (congenital
anomalies of the kidney and urinary tract).54,55 On one hand, the
term CAKUT reflects the fact that defects in the urinary system
can have very different phenotypes. It may also encourage urologists
and nephrologists to work together to tackle these complex diseases
that tend to affect both the kidney and the lower urinary tract.
Some investigators, however, dislike the term CAKUT because of
the perceived risk of blurring the pathological distinction of distinct
disease subtypes. In any case, it is clear that disturbance during
embryogenesis can affect multiple interconnecting processes for
the development of the urinary system, causing a wide spectrum of
defects in the kidney and urinary tract. Even if the primary molecular
and cellular lesions initially affect only part of the system, the structural and functional integration of the system eventually leads to
disruption of the development and integrity of other parts of the
urinary system. Thus, a systematic view of the development of the
urinary system is necessary even when a particular defect, such as
urinary tract obstruction, is being studied.
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Phenotypic Variations in Congenital Urinary Tract Defects
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It is common to see phenotypic variations in human patients and
animal models with urinary tract defects. We have seen variations
among affected individuals of the same genotype or even between
the left and right sides of the same individual. Variations are seen
in any organ systems, but some unique characters of urinary system
may have made it more prone to extreme variations. I will use two
hypothetical examples here to better illustrate this point (Fig. 7).
In the first example, a genetic defect slows UB budding to a degree
that the UB barely reaches the MM just in time to prevent its apoptosis. Other problems associated with this mutation then lead to the
development of urinary tract obstruction. However, any additional
disturbance, including intrinsic variations or random extrinsic factors,
may cause an additional minor delay in UB outgrowth, causing the
failure of the UB to reach MM before its degeneration and leading to
renal agenesis. This is similar to a scenario where you are running late
to catch a train. You may be lucky to get on it at the last second, or
your taxi to the station may hit one red light too many and you miss
it all together. The outcomes are very different (a train journey or
no train journey), but result from what could be considered a minor
difference in timing (one red light too many resulting in a delay of
seconds). By analogy, in kidney and urinary tract development, what
could be considered a minor quantitative difference (slower UB
outgrowth, for example) may be translated into qualitatively distinct
outcomes (renal agenesis or a kidney with urinary tract obstruction)
in affected individuals. In another hypothetical example, abnormal
intermediate mesoderm patterning causes the MM from both sides
www.landesbioscience.com
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that the Aqp2 defect would affect the medullary
gradient.
Dr. Jianghui Hou: Assistant Professor of Medicine,
Washington University School of Medicine Does the
lower urinary tract have transport function?
Dr. Chen: As you know, aquaporin 2 is expressed
in the collecting duct principal cells and serves as a
channel for water transport. However, in the lower
urinary tract, namely the ureter and the bladder, the
expression of Aqp2 is insignificant, if there is any
at all. In fact, we looked for Aqp2 expression in the
ureter and bladder using immunehistochemistry and
found no positive staining. We doubt that aquaporin
2 has any significant water reabsorptive function in
the lower urinary tract.
Dr. Jochen Lennerz, Molecular Genetic Pathology
Fellow, Anatomic & Molecular Pathology, Washington
University School of Medicine: You haven’t talked
about the innervations of the urinary tract. It has
been speculated that nervous system abnormalities
might be a cryptic cause of obstruction. Can you talk
about the neural control of peristalsis? The reason I
ask is because calcineurin has important functions in
the nervous system and is a target of a class of drugs.
Dr. Chen: That is a good question. One of the
first things we did when we began the calcineurin was
to examine the ureters from mutants and controls
histologically looking for differences in neural innervation. We saw no structural differences. However,
it is much harder to test functionally. Certainly, the
nerves are there and must be doing something. On
the other hand there are experiments showing that
the peristaltic process is primarily a myogenic. In the
movie I showed in the talk, pyeloureteral peristalsis
happened in the isolated urinary system without
any innervation in the dish. In fact, you can add

E.

Figure 7. Quantitative differences can be translated into
qualitatively distinct outcomes in urinary tract development, contributing the phenotypic variations. (A) In a
hypothetical scenario, a genetic defect affects UB budding
to a degree that the UB barely reaches the MM just in time
to prevent its apoptosis. Other problems associated with
this mutation then lead to the development of urinary tract
obstruction. Any additional disturbance may delay the UB
outgrowth further, causing the failure of the UB to reach
MM before its degeneration and leading to renal agenesis. This is similar to a scenario (depicted in B) where
you are running late to catch a train. You may be lucky to
get on it at the last second, or your taxi to the station may
hit one red light too many and you miss it all together. In
another hypothetical example (C), abnormal intermediate
mesoderm patterning causes the MM from both sides to
position closer to the midline than normal. The left and
right kidneys may develop relatively normally despite their
unusual positions. However, the close proximity of the MM
from both sides sets up an unstable state that any slight
variation may cause MM fusion and the occurrence of
horseshoe kidneys that tend to be obstructed. Therefore,
very slight and random variations may separate a rather
healthy state and a potentially very morbid state.
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neural blockers to the dish to block nerve activity without affecting
peristalsis.
There is no innervation following kidney and ureter transplantation, at least not in the initial stage. However, the ureter still
functions.
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